1. Home
  2. GBIO vs UONEK Comparison

GBIO vs UONEK Comparison

Compare GBIO & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • UONEK
  • Stock Information
  • Founded
  • GBIO 2016
  • UONEK 1980
  • Country
  • GBIO United States
  • UONEK United States
  • Employees
  • GBIO N/A
  • UONEK N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • UONEK Broadcasting
  • Sector
  • GBIO Health Care
  • UONEK Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • UONEK Nasdaq
  • Market Cap
  • GBIO 29.2M
  • UONEK 28.1M
  • IPO Year
  • GBIO 2020
  • UONEK N/A
  • Fundamental
  • Price
  • GBIO $0.52
  • UONEK $0.59
  • Analyst Decision
  • GBIO Strong Buy
  • UONEK
  • Analyst Count
  • GBIO 4
  • UONEK 0
  • Target Price
  • GBIO $7.33
  • UONEK N/A
  • AVG Volume (30 Days)
  • GBIO 1.8M
  • UONEK 285.8K
  • Earning Date
  • GBIO 08-06-2025
  • UONEK 08-07-2025
  • Dividend Yield
  • GBIO N/A
  • UONEK N/A
  • EPS Growth
  • GBIO N/A
  • UONEK N/A
  • EPS
  • GBIO N/A
  • UONEK N/A
  • Revenue
  • GBIO $24,556,000.00
  • UONEK $437,499,000.00
  • Revenue This Year
  • GBIO N/A
  • UONEK N/A
  • Revenue Next Year
  • GBIO N/A
  • UONEK N/A
  • P/E Ratio
  • GBIO N/A
  • UONEK N/A
  • Revenue Growth
  • GBIO 146.47
  • UONEK N/A
  • 52 Week Low
  • GBIO $0.30
  • UONEK $0.44
  • 52 Week High
  • GBIO $3.65
  • UONEK $1.57
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 66.42
  • UONEK 45.73
  • Support Level
  • GBIO $0.32
  • UONEK $0.55
  • Resistance Level
  • GBIO $0.59
  • UONEK $0.99
  • Average True Range (ATR)
  • GBIO 0.05
  • UONEK 0.15
  • MACD
  • GBIO 0.02
  • UONEK -0.01
  • Stochastic Oscillator
  • GBIO 76.34
  • UONEK 5.85

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: